Nanite
Curated by SignalManufacturer of programmable polymer nanoparticles
Overview
Developing AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The company's platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to create programmable and effective delivery vehicles for a wide range of genetic medicines. This approach aims to improve the efficacy and safety of gene therapies.
Key facts
- Founded
- 2021
- Headquarters
- Boston, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view